Publication

ABC-06 vertical bar A randomised phase III, multi-centre, open-label study of active symptom control (ASC) alone or ASC with oxaliplatin / 5-FU chemotherapy (ASC plus mFOLFOX) for patients (pts) with locally advanced / metastatic biliary tract cancers (ABC) previously-treated with cisplatin/gemcitabine (CisGem) chemotherapy

Lamarca, Angela
; 
Palmer, DH
; 
Wasan, HS
; 
Ross, PJ
; 
Ma, YT
; 
Arora, A
; 
Falk, S
; 
Gillmore, R
; 
Wadsley, J
; 
Patel, K
... show 10 more
Citations
Altmetric:
Abstract
Authors
Lamarca, Angela
Palmer, DH
Wasan, HS
Ross, PJ
Ma, YT
Arora, A
Falk, S
Gillmore, R
Wadsley, J
Patel, K
Anthoney, A
Maraveyas, A
Waters, JS
Hobbs, C
Barber, S
Ryder, D
Ramage, J
Davies, LM
Bridgewater, JA
Valle, Juan W
Affiliation
Department of Medical Oncology, The Christie NHS Foundation Trust / Institute of Cancer Sciences, University of Manchester, Manchester
Description
Date
2019
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Lamarca A, Palmer DH, Wasan HS, Ross PJ, Ma YT, Arora A, et al. ABC-06 | A randomised phase III, multi-centre, open-label study of active symptom control (ASC) alone or ASC with oxaliplatin / 5-FU chemotherapy (ASC+mFOLFOX) for patients (pts) with locally advanced / metastatic biliary tract cancers (ABC) previously-treated with cisplatin/gemcitabine (CisGem) chemotherapy. J Clin Oncol. 2019;37(15_suppl):4003-.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/622452
Embedded videos